Tellgen Corporation (300642)

Tellgen Corporation (300642)

$ 90

ESG +3

English Version

Date : 31 Jul 2020


Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company’s products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner